ARTICLES LIST

 

Total Results: 16203

Media ID Source Name Media Type Language Media Name Media Description Keywords Keywords Link to Article
6323 Centers for Disease Control and Prevention Html en The predicted impact of heart disease prevention and treatment initiatives on mortality in Lithuania, a middle-income country. null
stable heart disease0.594529
composite potential PPD0.566997
data0.559187
chronic heart disease0.570765
LVEF0.560259
symptomatic heart disease0.758192
acute events0.580905
Lithuanian mortality registry0.557087
potentially postponable deaths0.655985
heart failure0.593725
blood pressure0.58533
plausible range0.720694
patients0.578828
analysis0.56858
composite PPD0.606101
population0.601629
upper bound PPD0.563707
death rates0.577177
blood pressure level0.571346
unstable angina0.563782
intervention0.561149
United States0.655033
PPD0.616725
adequate physical activity0.619652
out-of-hospital cardiac arrest0.591592
ambulatory setting0.563024
lower bound PPD0.564267
Kaunas University Hospital0.593992
maximum plausible PPD0.578429
total mortality0.568704
heart disease0.926116
acute heart failure0.575845
acute cardiac events0.559352
Lithuanian population0.565199
cardiovascular disease0.565659
angina/other heart disease0.564242
largest PPD0.614955
people0.573757
apparent heart disease0.743981
heart disease risk0.575869
mortality rate0.571757
heart disease prevention0.595801
Thomas E. Kottke0.562974
interventions0.565077
heart disease continuum0.572715
mortality0.614966
ventricular ejection fraction0.558535
coronary heart disease0.590391
CLICK HERE
7490 Centers for Disease Control and Prevention Html en Veterans Health Activities - Gulf War Studies CDC's National Center for Environmental Health (NCEH) has taken the lead for HHS in addressing the health concerns of veterans of the Vietnam War and the Gulf War, and NCEH is working with the Departments of Defense and Veterans Affairs to protect the health of our future military forces.
MPEG0.741242
site0.541063
PDF0.544429
PPT0.837268
DOC0.733754
CLICK HERE
8518 Centers for Disease Control and Prevention Html en Preventing Chronic Disease | Retailer Adherence to Family Smoking Prevention and Tobacco Control Act, North Carolina, 2011 -CDC The Family Smoking Prevention and Tobacco Control Act regulates the sales and marketing of tobacco products in the United States; poor adherence by tobacco retailers may reduce the effectiveness of the Act’s provisions. The objectives of this study were 1) to assess whether and to which provisions retailers were adherent and 2) to examine differences in adherence by county, retailer neighborhood, and retailer characteristics.
North Carolina0.733301
new retailers0.49701
nonadherent retailers0.495081
New Hanover County0.527944
Tobacco Control Act0.994499
new provisions0.483149
eligible retailers0.499377
point-of-sale sales provisions0.499712
Tobacco control state0.510833
potential tobacco retailers0.580577
tobacco store0.492799
tobacco audit0.489337
retailer type0.501663
point-of-sale provisions0.663156
selling tobacco0.492497
Act point-of-sale provisions0.535866
certain tobacco products0.52462
differential adherence0.48621
grocery stores0.554179
Hanover County retailers0.549954
tobacco products0.700451
roll-your-own tobacco0.501875
retailer neighborhood characteristics0.644422
drug stores0.517837
Tobacco Products Scientific0.505832
cigarettes0.507701
Family Smoking Prevention0.524733
study0.506778
tobacco sales0.49992
convenience stores0.490249
Durham County retailers0.571282
New Hanover retailers0.508014
tobacco advertising0.498223
tobacco stores0.5063
racial/ethnic minority0.494934
tobacco vending machines0.544186
retailer characteristics0.502647
Buncombe County retailers0.541203
tobacco marketing0.483306
tobacco retailers0.758497
retailer adherence0.514504
new Tobacco Control0.530809
federal poverty guidelines0.563608
adherence0.587579
provisions retailers0.564813
smokeless tobacco products0.565844
tobacco brand–name event0.50935
smokeless tobacco0.656321
North Carolina counties0.536135
CLICK HERE
9746 Centers for Disease Control and Prevention Html en Histoplasmosis in a State Where It Is Not Known to BeEndemic - Montana, 2012-2013 Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.
H. capsulatum disease0.516363
recent travel0.597998
Human Services0.41911
H. capsulatum isolation0.510559
left parotid gland0.416294
clinically compatible illnesses0.552003
south central Montana0.434153
Clark City-County Health0.473448
bird droppings0.46623
itraconazole therapy0.459042
histoplasmosis0.600608
Ohio River0.453218
H. capsulatum culture0.514061
follow-up urine EIA0.422329
Montana0.595046
patients0.445152
weight loss0.470078
lymph node biopsy0.404272
endemic fungal infections0.40455
histoplasmosis endemicity0.514951
Randall J. Nett0.460003
left lung nodule0.406064
City-County Health Dept0.476656
uncontrolled diabetes mellitus0.481258
bat guano0.73612
diabetes mellitus type0.480428
night sweats0.407169
Montana residents0.437226
Histoplasma capsulatum0.528464
parotid gland0.44523
recent travel history0.419486
diagnostic delays0.429165
Health-care providers0.443149
patient0.652634
urine histoplasma antigen0.432039
southwest Montana0.440009
bat guano exposure0.427909
H. capsulatum0.962684
granulomatous inflammation0.408922
CT scan0.431381
erythrocyte sedimentation rate0.462822
H. capsulatum infection0.524406
lower lung0.414034
urine EIA0.446921
common clinical presentation0.409187
Low clinical suspicion0.406632
urine EIA tests0.409679
fungus Histoplasma capsulatum0.493899
chest radiograph0.413869
CLICK HERE
10725 Centers for Disease Control and Prevention Html en Preventing Chronic Disease | Multiple Chronic Conditions Among US Adults: A 2012 Update - CDC The objective of this research was to update earlier estimates of prevalence rates of single chronic conditions and multiple (>2) chronic conditions (MCC) among the noninstitutionalized, civilian US adult population. Data from the 2012 National Health Interview Survey (NHIS) were used to generate estimates of MCC for US adults and by select demographic characteristics. Approximately half (117 million) of US adults have at least one of the 10 chronic conditions examined (ie, hypertension, coronary heart disease, stroke, diabetes, cancer, arthritis, hepatitis, weak or failing kidneys, current asthma, or chronic obstructive pulmonary disease [COPD]). Furthermore, 1 in 4 adults has MCC.
Family Core0.664968
state-sponsored health plans0.660267
health care provider0.669072
Prev Chronic Dis0.829776
National Health Interview0.829361
non-Hispanic Asian adults0.670197
multiple chronic conditions0.802044
prevalence rates0.658045
Health Insurance Program0.662689
Disease Control0.664444
Sample Adult Core0.654403
public health systems0.665516
health care providers0.664373
health insurance coverage0.855923
multistage health survey0.676458
Vital Health Stat0.684352
non-Hispanic black adults0.670252
Health Interview Survey0.831106
MCC prevalence0.710882
national health surveys0.666836
Summary health statistics0.695035
insurance coverage status0.652436
chronic bronchitis0.674976
Chronic Disease0.6709
obstructive pulmonary disease0.655406
Public health insurance0.665421
United States0.709258
adults0.768261
prevalence estimates0.658394
earlier estimates0.660227
military health plans0.660098
public health concern0.664994
public health0.737428
health care0.674012
non-Hispanic white adults0.670271
Mental health conditions0.684357
sample adult0.679524
MCC0.755341
NHIS Core questionnaires0.651475
chronic conditions0.977276
different conditions0.65173
NHIS Family Core0.661626
public health problem0.676722
Public Health Service0.662564
single chronic conditions0.789971
Goodman RA0.664088
select demographic characteristics0.651355
coronary heart disease0.78866
Public Health Rep0.662394
CLICK HERE
11000 Centers for Disease Control and Prevention Html en What Do Parents Need to Know to Protect Their Children? - New Blood Lead Level Information Protecting children from exposure to lead is important to lifelong good health. Even low levels of lead in blood have been shown to affect IQ, ability to pay attention, and academic achievement. And effects of lead exposure cannot be corrected.
CDC0.49559
micrograms0.514803
new level0.500072
chelation therapy0.511382
97.5th percentile0.608357
reference level0.503245
concern0.433901
private health insurance0.570973
children’s levels0.518737
case management0.494943
major diseases0.493454
children0.973087
low levels0.501929
Nutrition Examination Survey0.576291
test result0.694635
high blood lead0.609157
risk factors0.49353
population-based survey0.498304
recent NHANES surveys0.579069
new recommendation0.497066
public health officials0.564994
future exposure0.521978
National Health0.498163
safe blood lead0.637153
doctors0.43537
reference value0.831098
current reference value0.579499
lead exposure0.966973
new lower value0.563608
medical treatment0.607526
academic achievement0.502669
Experts0.440577
United States0.496906
blood lead test0.616276
important step parents0.580286
new NHANES data0.571128
blood lead0.927224
deciliter0.514765
primary prevention0.516763
children’s blood0.558501
NHANES data0.652094
nutritional status0.494362
good health0.503991
blood test0.578888
dangerous lead sources0.638516
U.S. population0.498207
blood lead level0.729871
simple steps0.505472
blood lead distribution0.618796
CLICK HERE
12371 Centers for Disease Control and Prevention Image null Lung Cancer in African-American Men (600W x 2140H) null
CLICK HERE
13733 Centers for Disease Control and Prevention Image null Percentage of babies breastfeeding during the first year null
CLICK HERE
15274 Centers for Disease Control and Prevention Html en NIOSH Publications and Products - Injuries and Amputations Resulting from Work with Mechanical Power Presses (87-107) null
foot control0.216648
foot controls0.223975
hand speed0.335017
point0.211225
Occupational Safety0.224963
dual palm-button controls0.300058
palm buttons0.727145
dual palm buttons0.704203
male press operators0.317538
safety0.255308
power press operators0.63561
mechanical power presses0.974373
OSHA standards0.219886
foot0.265253
hand speeds0.221378
part-revolution clutches0.241431
cycling rate0.258985
young male press0.308869
critical cycling rate0.258611
operator hand speeds0.201424
individual press operators0.201028
young male operators0.23008
mechanical power press0.525074
mechanical press operators0.244905
press operators0.759574
OSHA0.316264
safety distance0.222783
power press injuries0.200283
foot-activated power presses0.210009
operation0.282371
CLICK HERE
15278 Centers for Disease Control and Prevention Html en For Clinicians: Evaluating and Managing Patients Exposed to Birds Infected with Avian Influenza Viruses of Public Health Concern A fact sheet for clinicians that gives guidance on evaluating and managing patients exposed to birds infected with HPAI H5 - CDC
avian influenza0.90155
molecular testing0.301218
infected birds0.282877
domestic poultry0.280892
infection control guidance0.316193
respiratory tract specimens0.277766
AI virus0.414752
public health risk0.271682
influenza A virus0.428818
Health care personnel0.278312
respiratory specimens0.276799
personal protective equipment0.271976
infection isolation room0.31686
Avian Influenza Guidance0.393767
influenza virus infections0.381307
enterically administered oseltamivir0.27269
AI virus infection0.370322
highly-pathogenic avian influenza0.403036
severe disease0.381415
pandemic potential0.278185
particular public health0.275181
visit Infection0.281355
neuraminidase inhibitor treatment0.272731
low-pathogenic avian influenza0.402763
wild aquatic birds0.284098
avian influenza viruses0.838244
novel influenza0.454029
infection control0.335491
novel avian influenza0.400553
Cause Severe Disease0.280092
Laboratory testing recommendations0.278473
influenza virus infection0.491978
associated AI outbreak0.289657
important clinical information0.282888
upper respiratory tract0.342096
sore throat0.275057
public health concern0.560604
illness0.295957
antiviral treatment decisions0.284109
avian influenza virus0.547367
poultry outbreak response0.279027
AI viruses0.447035
infection prevention0.319421
antiviral treatment0.335627
neuraminidase inhibitor0.277811
respiratory tract signs0.278962
additional respiratory specimens0.274766
Influenza A Viruses0.470374
CLICK HERE

 

 

 

Terms of Use | Privacy Policy
©2017 ARCHES Technology. All Rights Reserved.